Skip to Content
A home for paediatricians. A voice for children and youth.

Position statement

CPS

Imaging the term neonatal brain

Posted: Jul 18, 2018 | Reaffirmed: Jan 11, 2024

The Canadian Paediatric Society gives permission to print single copies of this document from our website. For permission to reprint or reproduce multiple copies, please see our copyright policy.

Principal author(s)

S Todd Sorokan; Ann L Jefferies; Steven P Miller; Canadian Paediatric Society, Fetus and Newborn Committee

Paediatr Child Health 2018, 23(5):322–328.

Abstract

Brain imaging is important for the diagnosis and management of sick term neonates. Although ultrasound and computed tomography may provide some information, magnetic resonance imaging is now the brain imaging modality of choice because it is the most sensitive technique for detecting and quantifying brain abnormalities and does not expose infants to radiation. This statement describes the principles, roles and limitations of these three imaging modalities and makes recommendations for appropriate use in term neonates. The primary focus is the brain of term infants with neonatal encephalopathy, many of whom are diagnosed with hypoxic-ischemic encephalopathy.

Keywords: Brain imaging; Encephalopathy; Newborn

Brain imaging is an important step in the diagnosis and management of sick neonates and especially for infants presenting with neonatal encephalopathy (NE), seizures, unexplained apneas, infections, metabolic disorders, birth injuries and suspected structural brain abnormalities. Information from imaging can help to define an underlying diagnosis, determine management and predict neurodevelopmental prognosis. This statement describes the principles, roles and limitations of three brain imaging modalities: cranial ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI). Recommendations for choosing the best investigation in common clinical situations are made, with focus on term infants with NE, many of whom are ultimately diagnosed with hypoxic-ischemic encephalopathy (HIE) [1].

METHODS

The literature on brain imaging in term infants published between 2000 and 2015 was identified using PubMED. Reference lists of publications were also reviewed. Original articles on diagnosis and prognosis were rated, and the strength of recommendations in this statement was graded according to classifications and levels described by the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society in their practice parameter for neonatal neuroimaging (Table 1) [2].

IMAGING MODALITIES

Ultrasound (US)

US imaging uses high-frequency sound waves emitted by a transducer to reflect off body structures. Returning sound waves (echoes) create an image, based on the frequency and strength of the signal and the time it takes to return to the transducer.

In newborns, the fontanelles provide an acoustic window for cranial imaging. US has several advantages over CT and MRI. It is safe (no ionizing radiation), technology is portable and usually readily available, and imaging is easily repeated, economical and does not require special preparation. However, in term infants with NE, US has limitations as a sole imaging modality, in part because the convex surfaces and posterior fossa may not be well visualized [3][4]. US is operator-dependent and subtle gray/white matter anomalies may be missed in less experienced hands. Transcranial Doppler US can measure cerebral blood flow noninvasively, which is helpful in diagnosing intracranial vascular malformations. Abnormal intracranial Doppler measurements can be early signs of hypoxic-ischemic injury. In centres where cranial US can be performed by experienced technologists and radiologists, US can be a useful initial evaluation tool of the term newborn brain.

Computed tomography (CT)

CT combines a series of x-ray images using a computer to create cross-sectional images. Although cranial CT has been used to assess for hemorrhage, brain injury and edema secondary to hypoxia-ischemic injury, venous sinus thrombosis, masses and structural abnormalities, MRI has generally supplanted CT for most of these indications.

In one comparison of neuroimaging findings for 48 term newborns with NE uniformly scanned with CT and MRI, MRI more readily detected cortical injury and focal/multifocal lesions, such as strokes and white matter injury [5]. CT and MRI similarly identified injury to the deep gray nuclei (basal ganglia and thalamus). A recent retrospective study showed that CT was less likely to detect injuries to the deep gray nuclei, brainstem and cerebellum, as well as strokes (P<0.001 for each) [6]. CT requires ionizing radiation, which should be avoided as much as possible in infants. Furthermore, because of lack of myelination in the newborn brain, gray/white matter contrast on CT is poor [7]. Nevertheless, when newborns are too unstable to adjust to necessary modifications in care or to undergo a long MRI procedure, CT can be considered as an alternative—at least initially—to detect the basal nuclei pattern of injury, which poses the most significant risk for adverse neurodevelopmental outcomes [5].

Magnetic resonance imaging (MRI)

MRI produces images using the body’s natural magnetic properties [8]. The scanner’s magnetic field makes the axes of hydrogen atom protons line up uniformly. Energy pulses from radio waves knock these axes out of alignment, followed by realignment or relaxation when this energy is turned off. The relaxation times produced by different tissues vary, creating contrast. T1 and T2 are relaxation constants that apply to the time taken for proton realignment. In T1-weighted images, water appears darker and fat lighter. In T2-weighted images, water appears lighter.

The water content of white matter is high in the nonmyelinated neonatal brain and signs of edema may be subtle but are usually still detectable using both T1 and T2 sequences. Diffusion MRI, such as diffusion-weighted imaging (DWI), measures the motion of water molecules when a magnetic gradient is applied in a particular direction, forcing the molecules to move in that direction [9]–[11]. Following acute cellular injury with resultant cytotoxic edema, the movement of water molecules is impaired, restricting diffusion. The rate of diffusion is expressed as the apparent diffusion coefficient (ADC). ADC maps are used to determine site and extent of injury. Areas with restricted diffusion have low ADC values and appear hyperintense or brighter on DWI and hypointense or darker on ADC maps. Fractional anisotropy measures directionality of diffusion, with higher values implying more directionality. Increasing myelination of white matter, seen as the brain matures, is one factor increasing fractional anisotropy [12]–[15].

Magnetic resonance spectroscopic imaging (MRSI) assesses regional brain metabolism by measuring the concentration of different biochemical compounds. N-acetylaspartate (NAA) and lactate are useful metabolites when evaluating metabolic changes associated with brain development and injury. NAA is normally found in high concentrations in neurons, and levels increase further as the brain matures [16]. When injury is present, NAA levels decrease with neuronal dysfunction or death. By contrast, brain lactate levels increase as cerebral oxidative metabolism is disturbed and energy sources fail, as seen with HIE or inborn errors of metabolism [17].

In term neonates, MRI has become the brain imaging modality of choice due to its superior sensitivity and specificity for detecting and quantifying brain abnormalities [18]. Also, MRI does not expose infants to ionizing radiation. Improved diagnostic accuracy and patient safety far outweigh the higher costs of MRI, including the transfer of at-risk newborns to a higher level of care. There are few contraindications to MRI because neonates rarely have implanted medical devices or metallic foreign bodies. However, it is essential to make sure that nearby equipment or objects do not contain ferromagnetic material that could become magnetized in the vicinity of an MRI system. Appropriate positioning, swaddling and timing of feeds can help to optimize effective scanning without the need for pharmacological sedation or general anaesthesia for most newborns. The development of MRI-compatible transport and monitoring equipment has increased accessibility and safety of MRI for critically ill neonates [19]. The standardized MRI sequences used for adults must be adapted for neonates because their brains have a higher water content and lower levels of proteins and lipids [20].

The brain develops dramatically in the third trimester of pregnancy and early extra-uterine life. Injury during this critical period can significantly alter function, including motor, cognitive, language and behavioural skills. However, it is important to recognize the neonatal brain’s potential for recovery and repair. MRI techniques are important for identifying the etiology and severity of brain abnormalities in the neonatal period as well as for understanding the scope for recovery and repair.

DISEASE PROCESS AND NEUROIMAGING

Neonatal encephalopathy (NE)

NE describes ‘a clinically defined syndrome of disturbed neurological function in the earliest day of life in the term infant’ [21]. NE should be considered when term newborns show signs of disturbed central nervous system function, such as apnea, abnormal tone and reflexes, altered consciousness or seizures. NE is a medical emergency because it causes significant morbidity and mortality [22][23] and often results from treatable conditions such as HIE, inborn errors of metabolism, infection, bilirubin toxicity and metabolic disturbances [23][24]. Cerebral dysgenesis, congenital infection and stroke may also present with encephalopathy in neonates [25]. Obtaining a comprehensive history is important for determining etiology. When the clinical history and imaging findings suggest hypoxic-ischemic injury, a diagnosis of HIE is assumed [1]. HIE is classified as mild, moderate and severe. Infants with mild HIE that resolves have a good neurological prognosis and neuroimaging does not enhance clinical management or the ability to prognosticate [2].

Hypoxic-ischemic encephalopathy (HIE): MRI

Brain injury associated with HIE is complex but can be simplified by considering two predominant patterns of brain injury: watershed and basal ganglia/thalamic. Visualization of injury depends on the severity, timing and abruptness of the hypoxic-ischemic event and on the timing and type of imaging study performed [5][26][27]. Both injury patterns have a spectrum of severity and extent based on individual circumstances.

The watershed or border zone pattern affects areas between the brain’s major arterial supplies and deep in the sulci, leading to edema, necrosis of the cerebral cortex and focal or regional infarction. On MRI performed between days 3 and 5 of life, this pattern is best seen as areas of restricted diffusion on DWI. MRSI may show a lactate peak in white matter in watershed areas [28]. Conventional T1- and T2-weighted images may still be normal at this point. Typically, from about day 8 and beyond, increased signal intensity on T1-weighted images is observed in the sulcal depths near the central and interhemispheric fissures, which indicates cortical necrosis. Deeper white matter can also be affected [29]. Maximal injury is evident at 10 to 14 days postinjury on T1- and T2-weighted images. This injury pattern is thought to be associated with prolonged partial hypoxia-ischemia (Class II to III studies).

The second pattern of injury in HIE is basal ganglia/thalamic, which is more often seen in acute, profound hypoxia-ischemia [30]. Deep grey matter structures have the highest metabolic rate and the greatest need for energy substrates. They sustain injury first, followed by the most active regions of the cerebral cortex, such as the sensorimotor (perirolandic) cortex. As with watershed injuries, restricted diffusion is maximal around the third day after the insult and is seen as a hyperintense signal on DWI in the basal ganglia/thalamic region. In severe total hypoxia-ischemia, higher signal intensity may present on T1-weighted images of the basal ganglia, even at this stage. Later, injury is best seen on T1-weighted images as increased signal intensity, initially in the ventro-lateral nuclei of the thalami, but also in all deep gray matter structures if injury is severe. A helpful neuroradiological sign in neonates more than 37 weeks’ gestation is loss of normal signal intensity in the posterior limb of the internal capsule (PLIC) [31] (Class II to III studies).

These two ‘pure’ pathways of injury are conceptual. In reality, the type, pattern, duration and variability in severity of hypoxia-ischemia are a continuum, and imaging yields mixed appearances. In one group of term neonates with the full range of NE, MRI was done at a median age of 6 days: 52% of infants had a watershed lesion of white and gray matter, 22% had basal ganglia/thalamic injury and 26% had a normal MRI [30]. When infants experienced a known sentinel event and an MRI was performed within the first 6 weeks of life (median age 10 days), similar patterns of injury were identified, with more infants having basal nuclei damage predominantly, as might be expected by the mechanism of injury [32].

When HIE is severe, generalized brain edema, which peaks 72 hours after the insult, can be seen on both CT and MRI. Identifiers include effacement of sulcal markings, closure of the Sylvian fissures, narrowing of the interhemispheric fissure and compression of the anterior horns of the lateral ventricles, giving a slit-like appearance. Similar changes may also be seen on US (Class II to III studies) T1-weighted images and DWI can show abnormal grey/white matter differentiation due to infarction and edema in the first week postinjury. DWI is more sensitive to acute brain injury than conventional MRI in the first days of life. Physiological factors, such as hypoglycemia, can modulate the pattern of hypoxic-ischemic injury [33].

Brain changes consistent with HIE take time to evolve and the extent of injury can be underestimated when imaging is performed too early [28]. In most cases, changes are present on MRI with DWI by day 3, worsening up to day 5, then normalizing [28][34]. Optimally, based on the experience of multiple investigators, both MRI with DWI and MRSI should be obtained in term newborns with NE between 3 and 5 days of life to confirm diagnosis and determine the extent of hypoxic-ischemic injury. This time frame is relevant for optimizing early management decisions [5][28][35]–[37] (Class I to III studies). A repeat MRI at 10 to 14 days is a helpful adjunct when clinical examination or clinical evolution is not consistent with early MRI findings or when diagnostic ambiguity persists.

Both main patterns of brain injury are clinically relevant predictors of neurodevelopmental outcome. Basal ganglia/thalamic lesions as well as abnormal signal intensity in the PLIC are associated with severe motor and cognitive disability, while watershed patterns are more closely associated with cognitive impairment than motor disability [30][31][38]–[40]. In one large study cohort, 60% to 70% of infants who sustained moderate basal ganglia/thalamic injury had cerebral palsy and 35% had a developmental quotient less than 70 [40]. Cerebral palsy was identified in 98% of infants with severe basal ganglia/thalamic injury [40][41]. The watershed pattern of injury also appears to predict language outcomes [29][42].

In the absence of MRI abnormalities, the likelihood of severe neurodevelopmental impairment is low [30][41][42]. In one study, a normal MRI was predictive of normal outcome [43]. One recent meta-analysis involving MRI scans acquired over the first weeks of life showed that deep gray matter lactate/NAA was the most accurate quantitative MRI biomarker for predicting neurodevelopmental outcome after NE [36]. The pooled sensitivity and specificity of lactate/NAA ratios were 82% and 92%, respectively; for conventional MRI they were 91% and 51%, respectively. Performance of MRSI, however, varies in different practice settings. Background noise, qualitative nature of data, varying performance on different machines and different methods of semiquantification make accurate assessment and evaluation of MRSI images a challenge.

Therapeutic hypothermia can affect MRI results and should be considered when determining image timing. MRI of cooled neonates detects most abnormal findings and patterns of brain injury follow similar evolution patterns to those observed in infants who are not cooled, although appearance of injury may be delayed [37][44] (Class II studies). Importantly, therapeutic hypothermia does not appear to affect the predictive value of conventional MRI for subsequent impairment [43][45][46]. Because most infants are cooled for 72 hours, MRI can be performed on days 4 to 5 of life, after rewarming.

Other imaging modalities for HIE

When performed on day 1 with careful attention to technique, US can identify significant antenatal brain injury [3]. Used meticulously, US has been shown to have high sensitivity and accuracy in detecting certain parenchymal lesions, although MRI shows more extensive lesions [47] (Class I study). Rebound increases in cerebral blood flow, which usually occur 24 hours to 36 hours after an hypoxic-ischemic insult, may be captured with Doppler studies of the anterior cerebral artery and provide additional evidence of brain insult [47]. These findings are more likely to be present with moderate-to-severe prolonged partial hypoxia-ischemia, when most of the cerebral hemisphere is involved, and less likely following acute profound asphyxia.

When MRI is not accessible, CT may be used for imaging neonates with HIE. However, the machine must be well calibrated to detect water and standardized imaging parameters must be used, both for kilovoltage and milliamperes per second (CT dose indices). The ‘window’ for accurately quantifying brain injury depends on identifying the extent of cerebral edema and is narrower with CT than for MRI [48]. Ideally, CT imaging should be performed 72 ± 12 hours after a suspected insult. Imaging performed earlier or later increases the risk of underestimating the extent of injury. When the timing is optimal and standardized imaging parameters are used, central grey matter, white matter and cerebral cortex involvement is seen as increasing edema (decreased attenuation). Basal ganglia/thalamic injury or total injury following acute profound hypoxia-ischemia is the lesion most accurately diagnosed with CT [5]. Even under optimal conditions, CT underestimates the severity of white matter and cerebral cortex injury [6] (Class II study).

OTHER CAUSES OF NE

Neonatal stroke

Arterial infarction (stroke) is more common in the neonatal period than at any other time in childhood [18]. Neonates typically present with seizures. Although US and CT may be useful, the consensus is that MRI is the most sensitive modality for neonates with suspected acute ischemia [49][50]. MRI may be used to identify the vessel and branch involved, the left middle cerebral artery being the most commonly affected. Acutely, stroke is seen as loss of grey/white matter differentiation on T1-weighted images, with hyperintense signal on DWI indicating restricted diffusion in the area of infarction. By the end of the first week, the lesion is clearly seen on conventional MRI, eventually evolving into tissue loss and cysts at 1 to 2 months of age [51][52]. The vascular classification of stroke in neonates is an important predictor of neurodevelopmental outcome [53].

Inborn errors of metabolism

Metabolic disease may be suspected from biochemical abnormalities or presenting signs. Recognizing characteristic imaging features may help with diagnosis. Cranial US can detect a variety of abnormalities, including cysts, calcification, white matter changes and structural abnormalities, which suggest metabolic abnormality [54]. However, MRI is considered the optimal modality. DWI and MRSI may be of diagnostic value with particular disorders, such as maple syrup urine disease, nonketotic hyperglycinemia or creatine deficiency [52][54]. When clinical signs and biochemical abnormalities suggest a metabolic disorder that requires urgent management, treatment should not be delayed to perform neuroimaging.

Traumatic brain injury

US can be used to identify intracranial hemorrhage, as can CT. The latter modality can also identify bone abnormalities and fractures, and better delineate hemorrhage. Subdural, subarachnoid and posterior fossa bleeds, as well as small intracranial hemorrhages, are not well visualized with US. MRI can be used to delineate injury further and is the modality of choice for assessing parenchymal injury. Newer MRI techniques have enhanced the detection of hemorrhage. CT is the modality of choice in trauma, when detection of bony fractures is a priority [2][7].

Cerebral dysgenesis and structural brain abnormalities

MRI is the preferred modality for assessing brain developmental abnormalities after birth due to its superior imaging of the cerebral cortex relative to US and CT [55].

Bilirubin encephalopathy

MRI has been used to assess infants with severe hyperbilirubinemia, with variable results. In newborns with acute bilirubin encephalopathy who develop chronic encephalopathy, increased T1 signal may be seen early on in both the globus pallidus and subthalamic nuclei. Later, increased T2 signal in the globus pallidus and subthalamic nuclei are typical findings associated with kernicterus [56]. Because of the risk for false-positive scans early on and poor predictive value, MRI should not be done routinely for neonates with severe hyperbilirubinemia in the absence of encephalopathy.

Congenital infection

Congenital infections, including syphilis, toxoplasmosis, rubella and cytomegalovirus, can cause CNS injury with subsequent developmental abnormalities. MRI is the preferred modality for assessing neonates with suspected or proven congenital infection, and should be performed in all infants with established cytomegaloviral infection [57][58]. Compared with US or CT, MRI has greater sensitivity in detecting CNS abnormalities in such cases [59]. While MRI may miss calcifications evident on CT, a normal MRI can predict favourable psychomotor development [59], and is recommended for all infants with symptomatic congenital cytomegaloviral infection as well as for infants with an abnormal US [57].

RECOMMENDATIONS

  1. Magnetic resonance imaging ( MRI) is the preferred imaging technique for examining the brain of term neonates who present with encephalopathy or a suspected brain injury or abnormality (Level A recommendation).
  2. Ultrasound (US) may be a useful first imaging modality, provided that trained and experienced technologists and radiologists are available. Although US can help identify hemorrhage, major structural anomalies or calcification, it is not recommended as the sole imaging modality in term neonates who present with moderate-to-severe encephalopathy, seizures or neurological signs suggestive of inborn errors of metabolism, brain injury or brain malformation, because the extent of injury is underestimated relative to MRI (Level A recommendation).
  3. Computed tomography (CT) may a useful first imaging modality in urgent situations, when MRI is not available, when an infant is too unstable to undergo MRI or when trauma or skull fracture is suspected (Level A recommendation).
  4. For infants presenting with hypoxic-ischemic encephalopathy (HIE), MRI should be performed at day 3 to 5 of life or, if the infant has received therapeutic hypothermia, once rewarming has taken place. Within practice settings, consistent timing of MRI scans is recommended to facilitate recognition of injury patterns on the specific sequences applied. Appropriate timing of the MRI is crucial for accurate diagnosis, for counselling parents about their infant’s prognosis and potential outcomes, and for guiding decisions about care. A repeat MRI at 10 to 14 days of age should be considered when the imaging and clinical features are discordant or when diagnostic ambiguity persists (Level A recommendation).
  5. When CT is used for imaging infants with HIE, it should be performed as close to 72 hours of the suspected insult as possible, ideally within 72 ± 12 hours. A subsequent MRI is also recommended (Level B recommendation).
  6. When a paediatric radiologist or neuroradiologist is not on site or it is not practical or possible to transfer an infant, images should be sent electronically for interpretation.
Table 1. Strength of recommendations
Level A Useful/predictive or not useful/predictive for given condition in specified population 
Level B  Probably useful/predictive or not useful/predictive 
Level C  Possibly useful/predictive or not useful/predictive 
Level U  Data inadequate or conflicting. Test/predictor is unproven
Based on ref. [2]
Abbreviations
ADC apparent diffusion coefficient
CT computed tomography
DWI diffusion-weighted imaging
HIE hypoxic-ischemic encephalopathy
MRI magnetic resonance imaging
MRSI magnetic resonance spectroscopic imaging
NAA N-acetylaspartate
NE neonatal encephalopathy
PLIC posterior limb of internal capsule
US ultrasound

Acknowledgements

This position statement has been reviewed by the Community Paediatrics and Acute Care Committees of the Canadian Paediatric Society. It was also reviewed by the Canadian Association of Child Neurology. The CPS acknowledges advisory input from the Canadian Association of Radiologists pertaining to imaging guidelines in the creation of this document.

CPS FETUS AND NEWBORN COMMITTEE

Members: Mireille Guillot MD, Leonora Hendson MD, Ann Jefferies MD (past Chair), Thierry Lacaze-Masmonteil MD (Chair), Brigitte Lemyre MD, Michael Narvey MD, Leigh Anne Newhook MD (Board Representative), Vibhuti Shah MD

Liaisons: Radha Chari MD, The Society of Obstetricians and Gynaecologists of Canada; William Ehman MD, College of Family Physicians of Canada; Roxanne Laforge RN, Canadian Perinatal Programs Coalition; Chantal Nelson PhD, Public Health Agency of Canada; Eugene H. Ng MD, CPS Neonatal-Perinatal Medicine Section; Doris Sawatzky-Dickson RN, Canadian Association of Neonatal Nurses; Kristi Watterberg MD, Committee on Fetus and Newborn, American Academy of Pediatrics

Principal authors: S. Todd Sorokan MD, Ann L. Jefferies MD, Steven P. Miller MD

CPS FETUS AND NEWBORN COMMITTEE (2023-24) 

Members:  Michael Narvey MD (Chair), Heidi Budden MD (Board Representative), Souvik Mitra MD MSC FRCPC, Eugene Ng MD FRCPC, Gabriel Altit MD, Nicole Radziminski MD, Anne-Sophie Gervais MD (Resident Member)                      

Liaisons:  William Ehman (College of Family Physicians of Canada), Chantal Nelson (Public Health Agency of Canada), Eric Eichenwald (American Academy of Pediatrics, Committee on Fetus & Newborn), Douglas Wilson (The Society of Obstetricians and Gynaecologists of Canada), Isabelle Milette (Canadian Association of Neonatal Nurses), Emer Finan MBBCH (CPS Neonatal-Perinatal Medicine Section)

References

  1. Volpe JJ. Neonatal encephalopathy: An inadequate term for hypoxic-ischemic encephalopathy. Ann Neurol 2012;72(2):156–66.
  2. Ment LR, Bada HS, Barnes P, et al. Practice parameter: Neuroimaging of the neonate: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2002;58(12):1726–38.
  3. Daneman A, Epelman M, Blaser S, Jarrin JR. Imaging of the brain in full-term neonates: Does sonography still play a role? Pediatr Radiol 2006;36(7):636–46.
  4. van Wezel-Meijler G, Steggerda SJ, Leijser LM. Cranial ultrasonography in neonates: Role and limitations. Semin Perinatol 2010;34(1):28–38.
  5. Chau V, Poskitt KJ, Sargent MA, et al. Comparison of computer tomography and magnetic resonance imaging scans on the third day of life in term newborns with neonatal encephalopathy. Pediatrics 2009;123(1):319–26.
  6. Barnette AR, Horbar JD, Soll RF, et al. Neuroimaging in the evaluation of neonatal encephalopathy. Pediatrics 2014;133(6):e1508–17.
  7. Mohan S, Rogan EA, Batty R, et al. CT of the neonatal head. Clin Radiol 2013;68(11):1155–66.
  8. Berger A. Magnetic resonance imaging. BMJ 2002;324(7328):35.
  9. Panigrahy A, Borzage M, Blüml S. Basic principles and concepts underlying recent advances in magnetic resonance imaging of the developing brain. Semin Perinatol 2010;34(1):3–19.
  10. Beaulieu C. The basis of anisotropic water diffusion in the nervous system—A technical review. NMR Biomed 2002;15(7-8):435–55.
  11. Hess CP, Barkovich AJ. Techniques and methods in pediatric neuroimaging. In: Barkovich AJ, ed. Pediatric Neuroimaging, 4th edn. Philadelphia, PA: Lippincott, Williams & Wilkins, 2000:8–9.
  12. Miller SP, Vigneron DB, Henry RG, et al. Serial quantitative diffusion tensor MRI of the premature brain: Development in newborns with and without injury. J Magn Reson Imaging 2002;16(6):621–32.
  13. Mukherjee P, Miller JH, Shimony JS, et al. Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation. AJNR Am J Neuroradiol 2002;23(9):1445–56.
  14. Drobyshevsky A, Song SK, Gamkrelidze G, et al. Developmental changes in diffusion anisotropy coincide with immature oligodendrocyte progression and maturation of compound action potential. J Neurosci 2005;25(25):5988–97.
  15. Prayer D, Barkovich AJ, Kirschner DA, et al. Visualization of nonstructural changes in early white matter development on diffusion-weighted MR images: Evidence supporting premyelination anisotropy. AJNR Am J Neuroradiol 2001;22(8):1572–6.
  16. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Hüppi PS. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48(6):949–58.
  17. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 2004;305(5680):99–103.
  18. van Laerhoven H, de Haan TR, Offringa M, Post B, van der Lee JH. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: A systematic review. Pediatrics 2013;131(1):88–98.
  19. Blüml S, Friedlich P, Erberich S, Wood JC, Seri I, Nelson MD Jr. MR imaging of newborns by using an MR-compatible incubator with integrated radiofrequency coils: Initial experience. Radiology 2004;231(2):594–601.
  20. Shroff MM, Soares-Fernandes JP, Whyte H, Raybaud C. MR imaging for diagnostic evaluation of encephalopathy in the newborn. Radiographics 2010;30(3):763–80.
  21. Nelson KB, Leviton A. How much of neonatal encephalopathy is due to birth asphyxia? Am J Dis Child 1991;145(11):1325–31.
  22. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351(19):1985–95.
  23. Volpe JJ. Hypoxic-ischemic encephalopathy: Clinical aspects. In: Neurology of the Newborn. Philadelphia, PA: Elsevier Health Sciences, 2008:314–73.
  24. Cowan F, Rutherford M, Groenendaal F, et al. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet 2003;361(9359):736–42.
  25. Pin TW, Eldridge B, Galea MP. A review of developmental outcomes of term infants with post-asphyxia neonatal encephalopathy. Eur J Paediatr Neurol 2009;13(3):224–34.
  26. Heinz ER, Provenzale JM. Imaging findings in neonatal hypoxia: A practical review. AJR Am J Roentgenol 2009;192(1):41–7.
  27. Rutherford MA. The asphyxiated term infant. In: Rutherford MA (ed.) MRI of the Neonatal Brain. London, UK: www.mrineonatalbrain.com/ (Accessed May 8, 2017).
  28. Barkovich AJ, Miller SP, Bartha A, et al. MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 2006;27(3):533–47.
  29. Steinman KJ, Gorno-Tempini ML, Glidden DV, et al. Neonatal watershed brain injury on magnetic resonance imaging correlates with verbal IQ at 4 years. Pediatrics 2009;123(3):1025–30.
  30. Miller SP, Ramaswamy V, Michelson D, et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 2005;146(4):453–60.
  31. Rutherford MA, Pennock JM, Counsell SJ, et al. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy. Pediatrics 1998;102(2 Pt 1):323–8.
  32. Okereafor A, Allsop J, Counsell SJ, et al. Patterns of brain injury in neonates exposed to perinatal sentinel events. Pediatrics 2008;121(5):906–14.
  33. Wong DS, Poskitt KJ, Chau V, et al. Brain injury patterns in hypoglycemia in neonatal encephalopathy. AJNR Am J Neuroradiol 2013;34(7):1456–61.
  34. Chau V, Poskitt KJ, Dunham CP, Hendson G, Miller SP. Magnetic resonance imaging in the encephalopathic term newborn. Curr Pediatr Rev 2014;10(1):28–36.
  35. Rutherford M, Counsell S, Allsop J, et al. Diffusion-weighted magnetic resonance imaging in term perinatal brain injury: A comparison with site of lesion and time from birth. Pediatrics 2004;114(4):1004–14.
  36. Thayyil S, Chandrasekaran M, Taylor A, et al. Cerebral magnetic resonance biomarkers in neonatal encephalopathy: A meta-analysis. Pediatrics 2010;125(2):e382–95.
  37. Gano D, Chau V, Poskitt KJ, et al. Evolution of pattern of injury and quantitative MRI on days 1 and 3 in term newborns with hypoxic-ischemic encephalopathy. Pediatr Res 2013;74(1):82–7.
  38. Chau V, Poskitt KJ, Miller SP. Advanced neuroimaging techniques for the term newborn with encephalopathy. Pediatr Neurol 2009;40(3):181–8.
  39. Rutherford M, Biarge MM, Allsop J, Counsell S, Cowan F. MRI of perinatal brain injury. Pediatr Radiol 2010;40(6):819–33.
  40. Martinez-Biarge M, Diez-Sebastian J, Rutherford MA, Cowan FM. Outcomes after central grey matter injury in term perinatal hypoxic-ischaemic encephalopathy. Early Hum Dev 2010;86(11):675–82.
  41. Martinez-Biarge M, Diez-Sebastian J, Kapellou O, et al. Predicting motor outcome and death in term hypoxic-ischemic encephalopathy. Neurology 2011;76(24):2055–61.
  42. Perez A, Ritter S, Brotschi B, et al. Long-term neurodevelopmental outcome with hypoxic-ischemic encephalopathy. J Pediatr 2013;163(2):454–9.
  43. Shankaran S, Barnes PD, Hintz SR, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Fetal Neonatal Ed 2012;97(6):F398–404.
  44. Wintermark P, Hansen A, Soul J, Labrecque M, Robertson RL, Warfield SK. Early versus late MRI in asphyxiated newborns treated with hypothermia. Arch Dis Child Fetal Neonatal Ed 2011;96(1):F36–44.
  45. Rutherford M, Ramenghi LA, Edwards AD, et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: A nested substudy of a randomised controlled trial. Lancet Neurol 2010;9(1):39–45.
  46. Cheong JL, Coleman L, Hunt RW, et al.; Infant Cooling Evaluation Collaboration. Prognostic utility of magnetic resonance imaging in neonatal hypoxic-ischemic encephalopathy: Substudy of a randomized trial. Arch Pediatr Adolesc Med 2012;166(7):634–40.
  47. Epelman M, Daneman A, Kellenberger CJ, et al. Neonatal encephalopathy: A prospective comparison of head US and MRI. Pediatr Radiol 2010;40(10):1640–50.
  48. Lupton BA, Hill A, Roland EH, Whitfield MF, Flodmark O. Brain swelling in the asphyxiated term newborn: Pathogenesis and outcome. Pediatrics 1988;82(2):139–46.
  49. Nelson KB. Perinatal ischemic stroke. Stroke 2007;38(2 Suppl):742–5.
  50. Kirton A, Armstrong-Wells J, Chang T, et al.; International Pediatric Stroke Study Investigators. Symptomatic neonatal arterial ischemic stroke: The International Pediatric Stroke Study. Pediatrics 2011;128(6):e1402–10.
  51. Dudink J, Mercuri E, Al-Nakib L, et al. Evolution of unilateral perinatal arterial ischemic stroke on conventional and diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2009;30(5):998–1004.
  52. Counsell SJ, Tranter SL, Rutherford MA. Magnetic resonance imaging of brain injury in the high-risk term infant. Semin Perinatol 2010;34(1):67–78.
  53. Kirton A, Deveber G, Pontigon AM, Macgregor D, Shroff M. Presumed perinatal ischemic stroke: Vascular classification predicts outcomes. Ann Neurol 2008;63(4):436–43.
  54. Leijser LM, de Vries LS, Rutherford MA, et al. Cranial ultrasound in metabolic disorders presenting in the neonatal period: Characteristic features and comparison with MR imaging. AJNR Am J Neuroradiol 2007;28(7):1223–31.
  55. Barkovich AJ, Raybaud CA. Neuroimaging in disorders of cortical development. Neuroimaging Clin N Am 2004;14(2):231–54, viii.
  56. Wisnowski JL, Panigrahy A, Painter MJ, Watchko JF. Magnetic resonance imaging of bilirubin encephalopathy: Current limitations and future promise. Semin Perinatol 2014;38(7):422–8.
  57. Kadambari S, Williams EJ, Luck S, Griffiths PD, Sharland M. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum Dev 2011;87(11):723–8.
  58. Lanari M, Capretti MG, Lazzarotto T, et al. Neuroimaging in CMV congenital infected neonates: How and when. Early Hum Dev 2012;88 (Suppl 2):S3–5.
  59. Capretti MG, Lanari M, Tani G, et al. Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection. Brain Dev 2014;36(3):203–11.

Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.

Last updated: Feb 7, 2024

In this section

Related information

statements and practice points

Paediatrics & Child Health